EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Spatially Resolved Association of Structural Biomarkers on Retinal Function in Non-Exudative Age-Related Macular Degeneration Over 4 Years

Marlene Saßmannshausen, Senem Döngelci, Marc Vaisband, Leon von der Emde, Kenneth R Sloan, Jan Hasenauer, Frank G Holz, Steffen Schmitz-Valckenberg, Thomas Ach

Investigative Ophthalmology & Visual Science · 2024

DOI: 10.1167/iovs.65.4.45 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2024. Written by Marlene Saßmannshausen and 8 co-authors. Institution: Department of Ophthalmology, University Hospital Bonn, Bonn, Germany. Major MEDLINE topics: Tomography, Optical Coherence, Visual Field Tests, Disease Progression, Visual Acuity. Cited 3 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY 4.0). Funded by: NEI NIH HHS.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Purpose

To longitudinally assess the impact of high-risk structural biomarkers for natural disease progression in non-exudative age-related macular degeneration (AMD) on spatially resolved mesopic and scotopic fundus-controlled perimetry testing.

Methods

Multimodal retinal imaging data and fundus-controlled perimetry stimuli points were semiautomatically registered according to landmark correspondences at each annual visit over a period of up to 4 years. The presence of sub-RPE drusen, subretinal drusenoid deposits, pigment epithelium detachments (PEDs), hyper-reflective foci (HRF), vitelliform lesions, refractile deposits, and incomplete RPE and outer retinal atrophy (iRORA) and complete RPE and outer retinal atrophy (cRORA) were graded at each stimulus position and visit. Localized retinal layer thicknesses were extracted. Mixed-effect models were used for structure-function correlation.

Results

Fifty-four eyes of 49 patients with non-exudative AMD (mean age, 70.7 ± 9.1 years) and 27 eyes of 27 healthy controls (mean age, 63.4 ± 8.9 years) were included. During study course, presence of PED had the highest functional impact with a mean estimated loss of -1.30 dB (P < 0.001) for mesopic and -1.23 dB (P < 0.001) for scotopic testing, followed by HRF with -0.89 dB (mesopic, P = 0.001) and -0.87 dB (scotopic, P = 0.005). Subretinal drusenoid deposits were associated with a stronger visual impairment (mesopic, -0.38 dB; P = 0.128; scotopic, -0.37 dB; P = 0.172) compared with sub-RPE drusen (-0.22 dB, P = 0.0004; -0.18 dB, P = 0.006). With development of c-RORA, scotopic retinal sensitivity further significantly decreased (-2.15 dB; P = 0.02). Thickening of the RPE-drusen-complex and thinning of the outer nuclear layer negatively impacted spatially resolved retinal sensitivity.

Conclusions

The presence of PED and HRF had the greatest prognostic impact on progressive point-wise sensitivity losses. Higher predominant rod than cone-mediated localized retinal sensitivity losses with early signs of retinal atrophy development indicate photoreceptor preservation as a potential therapeutic target for future interventional AMD trials.

Subjects

MeSH terms (MEDLINE)

Tomography, Optical CoherenceVisual Field TestsDisease ProgressionVisual AcuityVisual FieldsHumansFemaleAgedMaleMiddle AgedMacular DegenerationRetinal DrusenBiomarkersFollow-Up StudiesRetinal Pigment EpitheliumNight VisionRetinaAged, 80 and overFluorescein Angiography

Substances

Biomarkers

Authors and institutions

  • Department of Ophthalmology, University Hospital Bonn, Bonn, Germany.
  • Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.
  • Department of Internal Medicine III With Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg, Austria.
  • Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria.
  • Cancer Cluster Salzburg, Salzburg, Austria.
  • Department of Computer Science, University of Alabama at Birmingham, Birmingham, Alabama, United States.

Funding

  • NEI NIH HHS

Cite

APA

Saßmannshausen, M., Döngelci, S., Vaisband, M., von der Emde, L., Sloan, K. R., Hasenauer, J., Holz, F. G., Schmitz-Valckenberg, S., & Ach, T. (2024). Spatially Resolved Association of Structural Biomarkers on Retinal Function in Non-Exudative Age-Related Macular Degeneration Over 4 Years. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.4.45

Vancouver

Saßmannshausen M, Döngelci S, Vaisband M, von der Emde L, Sloan KR, Hasenauer J, et al. Spatially Resolved Association of Structural Biomarkers on Retinal Function in Non-Exudative Age-Related Macular Degeneration Over 4 Years. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.4.45

BibTeX
@article{Samannshausen2024,
  author = {Saßmannshausen, Marlene and Döngelci, Senem and Vaisband, Marc and von der Emde, Leon and Sloan, Kenneth R and Hasenauer, Jan and Holz, Frank G and Schmitz-Valckenberg, Steffen and Ach, Thomas},
  title = {Spatially Resolved Association of Structural Biomarkers on Retinal Function in Non-Exudative Age-Related Macular Degeneration Over 4 Years},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2024},
  doi = {10.1167/iovs.65.4.45}
}
Start for free →